Diabetes Insipidus, Nephrogenic
"Diabetes Insipidus, Nephrogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or AQUAPORIN-2; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.
Descriptor ID |
D018500
|
MeSH Number(s) |
C12.777.419.135.500 C13.351.968.419.135.500
|
Concept/Terms |
Nephrogenic Diabetes Insipidus, Type I- Nephrogenic Diabetes Insipidus, Type I
- Diabetes Insipidus, Nephrogenic, Type 1
- Diabetes Insipidus, Nephrogenic, Type I
- Diabetes Insipidus, Nephrogenic, X-Linked
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Insipidus, Nephrogenic".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Insipidus, Nephrogenic".
This graph shows the total number of publications written about "Diabetes Insipidus, Nephrogenic" by people in this website by year, and whether "Diabetes Insipidus, Nephrogenic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 1 | 1 | 2 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetes Insipidus, Nephrogenic" by people in Profiles.
-
Sevoflurane sedation and nephrogenic diabetes insipidus in patients affected with severe acute respiratory syndrome coronavirus 2. Eur J Anaesthesiol. 2021 04 01; 38(4):438-441.
-
Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue? Crit Care. 2019 09 05; 23(1):304.
-
Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis. J Am Soc Nephrol. 2018 11; 29(11):2658-2670.
-
Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial. BMC Psychiatry. 2018 07 16; 18(1):227.